May 20, 2021
HCmed Signs a Global Development Agreement with CSL Behring to develop a combination product On May 04, 2021, HCmed has announced the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop CSL Behring's plasma-derived immunoglobulin administered via HCmed’s new...
Read More...
May 19, 2021
Substance Use Disorder today is one of the most serious health concerns in almost every country. As per the Substance Abuse and Mental Health Services Administration (SAMHSA), “In 2018, approximately 20.3 million people aged 12 or older had a SUD in the past year in the US”. Of the total cases around 14.8 million h...
Read More...
May 18, 2021
InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in China InnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today announced the approval of Phase I clinical trial of its novel TYK2 (Tyrosine Kinase 2) inhibitor, ICP-332, by the China...
Read More...
May 17, 2021
Renal tubular acidosis (RTA) is a disease in which a person’s blood remains too acidic. It is a group of transport defects in the reabsorption of bicarbonate (HCO3−), the excretion of hydrogen ion (H+), or both when the kidneys fail to excrete acids into the urine. There are four types of RTA, among which distal, p...
Read More...
May 14, 2021
Neuropathy is the most usual complication that occurs due to diabetes, affecting up to about 50% of the patients. Painful diabetic neuropathy tends to take place in ~25% of the patients suffering from diabetes mellitus. These patients get treated in office settings, and it affects their quality of life. It also occ...
Read More...
May 13, 2021
Lilly, MiNA ink agreement to upregulate proteins using RNA Eli Lilly will utilise the power of MiNA Therapeutics’ proprietary small activating RNA (saRNA) technology platform to develop five novel drug candidates against diseases across the company’s core areas of focus. Eli Lilly declared a drug development ...
Read More...
May 12, 2021
Over the past three-four decades, there has been a significant increase in the number of morbidity and mortality due to asthma. As per the WHO’s 2019 data, an estimated 262 million people worldwide were affected by asthma and caused nearly 4,61,000 deaths. The low- and lower-middle-income countries registered the m...
Read More...
May 11, 2021
Abingworth Achieves Financial Close, Raises USD 582 Million Abingworth, a London-based venture capital firm, has announced the closing of its new Clinical Co-Development Fund 2 (ACCD 2) worth USD 582 million, however, the fund was aiming to gather USD $350 million. Not long ago, the company also closed ...
Read More...
May 10, 2021
Alagille syndrome (ALGS), also referred to as Alagille–Watson syndrome, is a rare autosomal dominant condition. Mutation in JAG1 or NOTCH2 gene causes the condition to occur, but most of the individuals’ mutation in the JAG1 gene is noted. The symptoms vary in patients, and the severity of the disease ranges from m...
Read More...
May 07, 2021
Benign prostatic hyperplasia, also called Benign prostatic hypertrophy or Benign prostatic obstruction, is a common condition in men as they get older. The prostate gland is a walnut-shaped gland present in men's reproductive systems, and its primary purpose is to produce a fluid that is secreted into semen. The pr...
Read More...